Much of the research, development and innovation necessary to make the government's new long-term plan for the NHS a reality will be driven by private ventures and early-stage companies, argues Andrew Aldridge
It might not have garnered many headlines, given what has been happening in Parliament around the UK's withdrawal from the EU, but amidst the ongoing Brexit debate, the government recently launched its NHS Long Term Plan. I doubt there has been much coverage within the financial services press about this plan either - yet it could yield further future opportunity for UK investors. According to the government, the Long-Term Plan is designed "to improve the quality of patient care and health outcomes" and, in that sense, it may well deliver some much-needed certainty for the health service...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes